Skip to content
healthcare.dev
Get a free key

Finazol

NDC 59088-008, Ferrous Fumarate, Folate, tablet, from PureTek Corporation.

Product NDC
59088-008
Status
Listed
Labeler
PureTek Corporation
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59088-008 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • VITAMIN A ACETATE1500 ug/1
  • ASCORBIC ACID200 mg/1
  • CHOLECALCIFEROL10 ug/1
  • .ALPHA.-TOCOPHEROL ACETATE, DL-45 mg/1
  • THIAMINE MONONITRATE3.25 mg/1
  • RIBOFLAVIN3.35 mg/1
  • NIACINAMIDE22.5 mg/1
  • PYRIDOXINE HYDROCHLORIDE6 mg/1
  • LEVOMEFOLATE CALCIUM1000 ug/1
  • METHYLCOBALAMIN26 ug/1
  • BIOTIN100 ug/1
  • PANTOTHENIC ACID15 mg/1
  • CALCIUM CARBONATE100 mg/1
  • FERROUS FUMARATE18 mg/1
  • POTASSIUM IODIDE25 ug/1
  • MAGNESIUM OXIDE50 mg/1
  • ZINC CITRATE30 mg/1
  • SELENIUM30 ug/1
  • CUPROUS OXIDE1 mg/1
  • MANGANESE SULFATE.75 mg/1
  • CHROMIUM NICOTINATE37.5 ug/1
  • MOLYBDENUM25 ug/1
  • POTASSIUM CHLORIDE24.5 mg/1
  • BORON25 ug/1

Pharmacologic classes

Analogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]; Calculi Dissolution Agent [EPC]; Cations, Divalent [CS]; Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]; Folate Analog [EPC]; Folic Acid [CS]; Increased Coagulation Factor Activity [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Magnetic Resonance Contrast Activity [MoA]; Nicotinic Acid [EPC]; Nicotinic Acids [CS]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Paramagnetic Contrast Agent [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Potassium Compounds [CS]; Potassium Salt [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]; Vitamin A [CS]; Vitamin A [EPC]; Vitamin B 6 [Chemical/Ingredient]; Vitamin B6 Analog [EPC]; Vitamin C [EPC]; Vitamin D [CS]; Vitamin D [EPC]

Package NDCNDC-11Package
59088-008-545908800085430 TABLET in 1 BOTTLE, PLASTIC (59088-008-54)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/24290823-022a-433b-e063-6394a90a8fd0

Use it

Look up 59088-008 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59088-008 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59088-008. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.